Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis

References

• Buxbaum J. The amyloidoses. In: Klippel JH, Dieppe PA, editor. Rheumatology. 2nd ed. London: Mosby; 1998. pp 8.27.1-10.
   Google Scholar
• Kyle RA, Gertz MA. Primary systemic amyloidosis. Clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45–59.
   Google Scholar
• Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900–2902.
   PubMed Web of Science ®Google Scholar
• Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673–680.
   PubMed Web of Science ®Google Scholar
• Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Serum reference intervals and diagnostic ranges for free k and free l immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437–1444.
   PubMed Web of Science ®Google Scholar
• Abraham RS, Katzmann JA, Clark RJ, Bradwell AR, Kyle RA, Gertz MA. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003;119:274–278.
   Google Scholar
• Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, Hawkins PN. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003;122:78–84.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Gono T, Shimojima Y, Hoshii Y, Ikeda S. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis. Amyloid: J Protein Folding Disord 2003;10:110–116.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Gono T, Shimojima Y, Sakashita K, Koike K, Ikeda S. Evaluation of intensive chemotherapy in primary systemic AL amyloidosis. Usefulness of flow cytometric analysis of plasma cells in the bone marrow. Amyloid: J Protein Folding Disord 2003;10:250–256.
   PubMed Web of Science ®Google Scholar
• Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001;51:264–270.
   PubMed Web of Science ®Google Scholar
• The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma, and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749–757.
   Google Scholar
• Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O’Hara C, et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL amyloidosis: survival and responses in 25 patients. Blood 1998;91:3662–3670.
   PubMed Web of Science ®Google Scholar
• Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, Iwato K, Kuramoto A. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 1993;82:564–570.
   PubMed Web of Science ®Google Scholar
• Huang N, Kawano MM, Harada H, Harada Y, Sakai A, Kuramoto A, Niwa O. Heterogeneous expression of a novel MPC-1 antigen on myeloma cells. Possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells. Blood 1993;82:3721–3729.
   Google Scholar
• Mahmoud MS, Ishikawa H, Fujii R, Kawano MM. Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6. Blood 1998;92:3887–3897.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Mahmoud MS, Fujii R, Abroun S, Kawano MM. Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma. Leuk Lymphoma 2000;39:51–55.
   PubMed Web of Science ®Google Scholar
• Kawano MM, Mahmoud MS, Huang N, Lisukov IA, Mihara K, Tsujimoto T, Kuramoto A. High proportions of VLA-5immature myeloma cells correlated well with poor response to treatment in multiple myeloma. Br J Haematol 1995;91:860–864.
   PubMed Web of Science ®Google Scholar
• Clark RJ, Katzmann JA, Abraham RS, Lymp JF, Kyle RA, Bradwell AR. Detection of monoclonal free light chains by nephelometry: normal ranges and relative sensitivity. Clin Chem 2001;47:a27
   Google Scholar
• Fujii R, Ishikawa H, Mahmoud MS, Asaoku H, Kawano MM. MPC-1-CD49eimmature myeloma cells include CD45 + subpopulations that can proliferate in response to IL-6 in human myelomas. Br J Haematol 1999;105:131–140.
   PubMed Web of Science ®Google Scholar